MicroRNAs (miRNAs) diagnostics can be useful for diagnosing or confirming miRNA abundance and are used in screening tests and to assess changes in miRNAs in vivo. At present, the use of traditional nucleic acid amplification assays to detect miRNAs has been limited in laboratory environment because of the time, equipment, and technical expertise required to perform these assays. A specialized, rapid affordable miRNA detection system is necessary when there are limited resources or point-of-care testing needs. We designed a portable and affordable fluorescence-based miRNA detection system based on isothermal signal amplification technology, using SYBR Green II as a fluorescent dye. To reduce costs, we chose LED as a light source and designed the corresponding optical path for LED. The portable detection system shows results consistent with those by real-time PCR, and can be used to detect miR-183 with a limit of detection of approximately 2 fmol. We used the system to detect miR-183 in tissues and blood from patients with hepatocellular carcinoma (HCC). The results from the portable detection device were compared with those from clinical trials and indicated that the miR-183 fluorescence signal could successfully identify HCC and provide information related to cancer progression.
Introduction
MicroRNAs (miRNAs) are non-coding, small RNAs with an average length of 22 nucleotides [1] [2] [3] . These RNAs play an important role as negative regulators of gene expression by binding to 3 non-translated regions of mRNAs to the mediate cleavage of mRNA or prevent the synthesis of proteins in various cellular pathways [4] . MiRNAs have been identified as potential prognostic and diagnostic biomarkers for many diseases.
To date, many approaches have been applied to detect miRNA, such as microarray-based detections, northern blotting, fluorescence-based detections, and electrochemical biosensors [5] [6] [7] . Most of the miRNA detection systems are based on fluorescence because of the high selectivity, sensitivity, cost-effectiveness, and high throughput of this approach [8] . In addition, these assays are flexible in their fluorescence lifetime, wavelength, and intensity. Real-time PCR (RT-PCR) is a useful detection tool that is highly accurate and sensitive for the detection of miRNAs [9] . Nevertheless, specific instruments are needed to control temperature change precisely. It is costly and inefficient for the rapid diagnosis of disease, requiring simultaneous processing of large numbers of samples and rapid high-throughput DNA amplification [10] . Many signal amplification methods based on fluorescence have been developed, including exponential amplification reactions (EXPAR) and rolling circle amplification (RCA) methods [11] [12] [13] [14] . EXPAR requires a trigger in the template, and the template sequence must contain a genome with adjacent notch enzyme recognition sites, which prevents EXPAR from being used widely for nucleic acid detection. RCA amplification technology is advantageous for rapid detection. It does not require special temperature control equipment and amplify many templates in a short time. However, the current methods based on RCA are complicated and require costly instruments. A specialized, rapid, and affordable miRNA detection system is necessary when there are limited resources or point-of-care testing needs.
To overcome these limitations, we designed a novel simple, affordable, and portable miRNA detection system based on RCA and the fluorescent dye SYBR Green II. The system is designed to detect very weak light signals using background light compression suppression [15] . A schematic diagram of the system's optical detection mechanism is shown in Fig. 1A . To reduce the cost of the system, we chose LED as the light source. Because the maximum absorption wavelength and maximum emission wavelength of the SYBR Green II fluorescent dye are approximately 497 and 520 nm, the light source should match the maximum absorption wavelength. The closest LED we could obtain commercially had a central wavelength (CWL) of 480 nm. Although the fluorescence efficiency of 480 nm is slightly less than that of 497 nm, an effective fluorescence signal can still be obtained using an effective filter and detector. A filter with a CWL of 480 nm, which matched with that of the LED, was installed before the LED. In addition, LED has a large beam divergence, low energy density, and poor beam quality, which is not conducive to energy concentration. To solve this problem, several lenses were installed after the filter. Then, the light that passed through the battery of lens was reflected and focused by a dichroscope mirror and illuminated on the fluorescent substance to be measured. We used a common PCR tube as an RCA reaction vessel. The mechanical design of the sample pool conformed to the shape of the PCR tube, which ensured that the position of the PCR tube was the same for each measurement. The solution volume was quantified by a pipette for each measurement. This reduced the system measurement error and improved system reproducibility. After the fluorescent substance absorbed the excitation light energy, it emitted fluorescent photons. Because the dichroscope mirror has a high transmittance of the fluorescent wavelength, the fluorescent photons can pass through the mirror. The fluorescent photons were filtered to remove background light, including the excitation wavelength. A battery of lens was installed before the filter to ensure that all fluorescent photons could be received by the detector. Finally, the detector received the fluorescent photons, completed photoelectric conversion, and provided a fluorescence intensity value. To ensure sensitive detection of fluorescence signals, we chose photomultiplier tube (PMT) as a detector. The portable miRNA detection system is shown in Fig. 1B .
The results from this portable detection system were consistent with those by RT-PCR, and were used to detect miR-183 with a limit of detection of approximately 2 fmol. We detected miR-183 in tissues and blood of patients with hepatocellular carcinoma (HCC) and normal controls. We compared miR-183 expression in cirrhotic and normal samples, and the results suggested that this system is valuable for early HCC diagnosis.
Materials and Methods

Portable miRNA detection system and reagent
The light source portion of the system is an LED (480-485; Xilan, Shenzhen, China; CWL 480 nm, FWHM 35 nm). To reduce the interference from external stray light and improve the signalto-noise ratio, the filter-matched LED and filter-matched emission wavelength of SYBR Green II were added to the device in the light emitter and receiving path, respectively. A 480-nm band pass filter (Optical Engineering Center of Anhui Institute of Optics and Fine Mechanics; CWL 480 nm, FWHM 50 nm) and battery of lens (Optical Engineering Center of Anhui Institute of Optics and Fine Mechanics, Hefei, China) were selected for light emission. The detection portion of the system consisted of a PMT (CR314; Hamamatsu, Japan), 520-nm band pass filter (520FS10-12.5; Andover, CA, USA), and battery of lens (Optical Engineering Center of Anhui Institute of Optics and Fine Mechanics, Hefei, China). A dichroscope (Optical Engineering Center of Anhui Institute of Optics and Fine Mechanics, Hefei, China) was selected to reflect the emitting light and transmit fluorescence to the detection portion. Data from the system was acquired by a computer in real time.
FIG. 1
Schematic representation of the optical inspection process and physical map. (A) Schematic diagram of the optical detection process. (B) The portable miRNA detection system.
The oligonucleotides (via HPLC purifications) applied in this study were purchased from Genscriptin Nanjing (Nanjing, China). All the ligases (T4 RNA ligase I, T4 RNA ligase II, and T4 DNA ligase) and the phi29 DNA polymerase were purchased from New England Biolabsin (Ipswich, MA, USA). For extraction of miRNA from FFPE and blood, an miRNAprep Pure FFPE Kit and miRcute Serum/plasma miRNA Isolation Kit from Tiangen Biotech in Beijing (China) were used. dNTPs were obtained from Sangong in Shanghai (China) and SYBR Green from TaKaRain (Dalian, China). All of the solutions were made with super purified water.
Patient specimens
Fifty-two samples of HCC, with the corresponding tissues, and 10 liver tissues were obtained from patients who underwent entire surgical resections in Chinese Academy of Sciences, Cancer Hospital of Hefei Institutes of Physical Science (CAS) (Hefei, China) from January 2015 to January 2017. All the samples were immediately frozen in liquid nitrogen until they were used in further investigations. The protocol for this study was approved by the institutional review board of the Cancer Hospital of the Hefei Institutes of Physical Science, CAS. The clinical features of the patients are listed in Table 1 .
RCA assay
Equal sample (0.5 μL) of the targeted miRNA (1 μM) and the padlock probe were incubated at a temperature of 37
• C for 10 Min. The incubation system consisted of T4 RNA ligase 2 with a ligation buffer of 2 mM MgCl 2 , 50 mM Tris-HCl (pH 7.5), 400 μM ATP, and 1 mM DTT. During the 30-Min incubation period, ligase circularized the products via padlock probes. The 1 μL circularized solution was added to the reaction buffer, 0.1 μL SYBR Green II and 5 μL dNTP. The intensity of fluorescence was monitored over 10 Min to obtain a baseline measure at 25-30
• C. Phi29 DNA polymerase (10 U) was added, and the intensity of fluorescence was monitored for 30 Min. For reproducibility of the miRNA detection system, the fluorescence intensity of 6-FAM with concentrations of 0.1, 0.3, 0.5, 0.7, and 1 μmol were measured. The different concentrations of 6-FAM were measured 10 times with the portable miRNA detection system, and the data were recorded independently.
System performance
To test the sensitivity of the miRNA detection system, a series of miR-183 samples, from 0 to 6 fmol, was prepared in 0.5 fmol increments, and the miR-183 fluorescence was measured using the portable miRNA detection system after the RCA assay.
To test the specificity of the miRNA detection system, similar amounts of miR-183, miR-182, and miR-96 were prepared and padlock miR-183 was used as the padlock for miR-183, miR-182, and miR-96. Fluorescence was measured with the portable miRNA detection system after the RCA assay. 
Absolute quantification of miRNA-183 fluorescence in HCC cells
Normal liver cells LO2 and HCC cells HepG2, Bel7402, and Huh-7 were cultured. Then, 100, 1,000, and 10,000 of LO2, HepG2, Bel7402, and Huh-7 cells, respectively, were collected, and miRNA-183 was extracted from cells using an miRNAprep Pure FFPE Kit (Tiangen) according to the method in the instructions. Fluorescence was measured using the portable miRNA detection system after the RCA assay.
Detection of the miR-183 fluorescence signal in HCC tissues
MiRNA from HCC tissues was extracted according to the instructions of the miRNAprep Pure FFPE Kit (Tiangen). The purity of miR-183 was measured using a NanoDrop2000 device according to the manufacturer's recommendations. After the TCA assay, fluorescence of each sample was detected by the portable miRNA detection system. For comparison, an immunohistochemical analysis was performed. All the paraffin-embedded HCC tissues, as well as the surrounding non-tumor tissues, were prepared in 4-μm-thick sections. The slides were deparaffinized with xylene, rehydrated with distilled water and an alcohol gradients, and then heated at 100
• C for a period of 15 Min in a retrieval buffer (pH 6.0, 10 mM citrate buffer, pH 8.0, 1 mM EDTA). After antigen retrieval, the microarrays were incubated in 10% hydrogen peroxidase of phosphate-buffered saline (PBS) for 10 Min, and then in 10% normal goat serum for 30 Min. Antibody anti-CD34 was added, and then, the microarrays were incubated at 4
• C. After three washes, with PBST (PBS with 0.1% tween-20), each lasting for 5 Min, a secondary antibody was incubated with the microarrays at room temperature for 30 Min. The arrays were counterstained with eosin and hematoxylin. The KF-PRO Digital Slide Scanning System from Kongfong Biotech International Co. (Ningbo, China) was applied to visualize the corresponding signals.
Detection of the miR-183 fluorescence signal in blood samples from patients with HCC
Ten blood samples from patients with HCC and two normal control samples were prepared for miR-183 fluorescence signal detection. The pathological grade of HCC samples was confirmed by anti-CD34 antibody immunohistochemistry. Five milliliters of blood samples were collected. MiRNA from blood was extracted according to the instructions of the miRcute Serum/plasma miRNA Isolation Kit (Tiangen). The purity of miR-183 was measured with a NanoDrop2000 device according to the manufacturer's recommendations. After the RCA assay, fluorescence of each sample was detected with the portable miRNA detection system.
Results
System performance
The excitation light of 6-FAM fluorescein is 495 nm, and the emission wavelength is 521 nm. These wavelengths are similar to the wavelength range of the SYBR Green II fluorescent dye selected for this study. So 6-FAM fluorescein is selected as a standard reagent to test the system. Fluorescence detected with a RT-PCR system was similar to the fluorescence value detected with the portable miRNA detection system designed in this study (Fig. 2) . Reproducibility indicates the consistency between results of multiple measurements of the same sample. The results are shown in Table 2 . Equation (1) was used to calculate the coefficient of variation (CV).
, x is the fluorescence intensity value measured each time, n is the number of measurements, andx is the average value from n measurements. The CV results were cv 0.1 = 0.99%, cv 0.3 = 0.68%, cv 0.5 = 0.38%, cv 0.7 = 0.34%, and cv 1 = 0.24%. These results showed that the system had good reproducibility.
FIG. 2
Comparison A series of miR-183 samples were prepared and test with our portable miRNA detection system. We showed that the system could detect miR-183 with a limit of detection of approximately 2 fmol (Fig. 3A) . When the reagent concentration reached or exceeded 2 fmol, the fluorescence signal could be distinguished from the background with the miRNA portable detection device. When the reagent concentration was between 0 and 2 fmol, the miR-183 signal overlapped with that of the background noise, indicating that the reagent concentration was too low for detection. 
FIG. 4 Absolute quantification of miR-183 fluorescence in HCC cells. The expression of miR-183 in HCC cells (HepG2, Bel7402, and Huh-7) was significantly higher than that in normal liver cells (LO2), and the expression of miRNA-183 in HCC cells increased with an increase of the number of cells.
To investigate the specificity of miR-183 using the portable miRNA detection system, similar amounts miR-183, miR-182, and miR-96 were detected using our portable miRNA detection system. Only the miR-183 signal could be distinguished; the miR-182 and miR-96 signals overlapped with the background noise and could not be detected (Fig. 3B) .
Taken together, these results indicate that the device is able to specifically detect an miR-183 signal as low as 2 fmol, and that the portable miRNA detection device can distinguish between the miRNA fluorescence signal and the background signal.
Absolute quantification of miR-183 fluorescence in HCC cells
After quantification, the expression of miR-183 in HCC cells was found to be different from that in normal cells. MiR-183 expression was highest in Bel7402, and lowest in HepG2. However, the expression of miR-183 in HCC cells (HepG2, Bel7402, and Huh-7) was significantly higher than that in normal liver cells (LO2), and the expression of miRNA-183 in HCC cells increased as the number of cells increased (Fig. 4) .
Detection of the miR-183 fluorescence signal in HCC tissues
We detected the miR-183 fluorescence signal in 52 HCC tissues, adjacent non-tumor tissues, and 10 normal liver tissues using the miRNA detection device. In 52 HCC specimens, fluorescence values were dramatically upregulated in comparison with those of the adjacent non-tumor specimens (P < 0.01) and normal liver tissue (P < 0.01) (Fig. 5A) . Moreover, we found a positive correlation between fluorescence values and HCC grades. The miR-183 fluorescence signal values were higher in HCC samples with grades III-IV than in grades I-II (P < 0.01). Consistent with these results, the levels of miR-183 expression were higher in HCC tissues than in adjacent non-tumor specimens (P < 0.05) and normal liver tissues (P < 0.01) (Fig. 5B) . Taken together, these results indicate that values of the miR-183 fluorescence signals detected with the miR-183 device may be good predictor of HCC development and progression.
Detection of the miR-183 fluorescence signal in blood samples from patients with HCC
The sensitivity and specificity of miRNA detection by the miRNA detection device supported the use of the device for HCC clinical detection. Ten blood samples from HCC patients and two from normal controls were prepared for miR-183 fluorescence signal detection. The pathological grade of HCC samples was confirmed by anti-CD34 antibody immunohistochemistry (Fig. 6A) . Five milliliters of blood samples were collected, miRNA was extracted, and the miR-183 fluorescence signal was detected. Similar to the results above (Fig. 5A) , the fluorescence values for HCC patients were dramatically upregulated in comparison with those from the normal blood samples (P < 0.01) (Fig. 6B) . Moreover, the miR-183 fluorescence signal values were higher in HCC grades III-IV than in grades I-II.
FIG. 5
Detection 
Discussion
In this study, we developed and demonstrated the use of a portable miRNA detection system to detect miRNA in tissue and blood from patients. We used an LED as a light source, a common PCR tube as a RCA reaction vessel, and PMT as a fluorescence detection device [16, 17] . Both are convenient experimental operations and yield an easy-to-detect fluorescence signal. These methods also facilitate device miniaturization, are low cost, and show improved sensitivity to rapidly detect miRNA. The total cost of the detection system is approximately $500, which is several times less than that of current system. The system shows good reproducibility, and the results are consistent with those of RT-PCR. We used the miRNA detection device to sensitively detect miR-183 fluorescence signals. With this device, miR-183 expression levels in the blood of patients with HCC were detected using fluorescence detection principals and the isothermal RCA technique. Detection of the miR-183 fluorescence signal by the portable detector led to an accurate prediction of HCC development and progression. Additionally, the limit of detection for miR-183 was as low as 2 fmol, and the miRNA portable detection device specifically distinguished between the miRNA fluorescence signal and baseline noise.
This system can be applied for the early and rapid detection of specific miRNAs associated with diseases such as coronary heart disease and cancer [18, 19] , for which early diagnosis is of great importance. This portable, affordable, rapid miRNA detection system shows high amplification efficiency, is small in size, and is easy to operate, suggesting great potential as a point-of-care testing product that is suitable for use in homes or small-and medium-sized community hospitals [20, 21] . Therefore, the portable miRNA detection system has strong future prospects. 
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